
  
    
      
        Background_NNP
        The_DT factors_NNS responsible_JJ for_IN the_DT age-related_JJ incidence_NN of_IN
        post-diarrheal_JJ hemolytic_JJ uremic_JJ syndrome_NN (_( HUS_NNP )_) are_VBP unknown_JJ ._.
        Clinical_NNP data_NNS indicate_VBP that_IN the_DT peak_NN incidence_NN of_IN HUS_NNP
        occurs_VBZ around_IN two_CD years_NNS of_IN age_NN ,_, but_CC the_DT disease_NN clearly_RB
        occurs_VBZ in_IN significant_JJ numbers_NNS of_IN older_JJR children_NNS [_NN 1_CD ]_NN ._.
        Population-based_NNP studies_NNS suggest_VBP that_IN there_EX is_VBZ a_DT decline_NN in_IN
        the_DT incidence_NN of_IN HUS_NNP from_IN a_DT peak_NN at_IN age_NN 1_CD -_: 2_CD years_NNS until_IN a_DT
        nadir_NN at_IN about_IN age_NN 11_CD years_NNS [_NN 1_CD 2_CD ]_NN ._. In_IN addition_NN ,_, a_DT
        case-control_JJ study_NN of_IN the_DT Washington_NNP State_NNP outbreak_NN of_IN HUS_NNP
        revealed_VBD that_IN the_DT mean_JJ age_NN of_IN patients_NNS with_IN HUS_NNP was_VBD 8_CD
        years_NNS ,_, while_IN the_DT mean_JJ age_NN of_IN patients_NNS without_IN HUS_NNP was_VBD 15_CD
        years_NNS [_NN 3_CD ]_NN ._. These_DT studies_NNS raise_VBP the_DT possibility_NN ,_,
        therefore_RB ,_, that_IN the_DT appearance_NN or_CC disappearance_NN of_IN a_DT factor_NN
        or_CC factors_NNS in_IN adolescents_NNS and_CC adults_NNS reduces_VBZ susceptibility_NN
        to_TO end-organ_JJ injury_NN in_IN HUS_NNP ._.
        HUS_NNP is_VBZ thought_VBN to_TO be_VB due_JJ ,_, at_IN least_JJS in_IN large_JJ part_NN ,_, to_TO
        Shiga_NNP toxin_NN (_( Stx_NNP )_) -_: mediated_JJ cell_NN toxicity_NN [_NN 4_CD ]_NN ._. Since_IN the_DT
        kidney_NN is_VBZ a_DT primary_JJ target_NN of_IN Stx_NNP in_IN patients_NNS with_IN HUS_NNP ,_, it_PRP
        has_VBZ been_VBN hypothesized_VBN that_IN the_DT preferential_JJ renal_JJ injury_NN
        occurring_VBG in_IN children_NNS with_IN HUS_NNP is_VBZ related_VBN to_TO heightened_VBN
        renal_JJ susceptibility_NN to_TO Stx_NNP in_IN this_DT age_NN group_NN ._. Such_JJ
        increased_VBN renal_JJ sensitivity_NN to_TO Stx_NNP in_IN children_NNS ,_, if_IN it_PRP does_VBZ
        indeed_RB exist_VB ,_, could_MD be_VB due_JJ to_TO a_DT wide_JJ variety_NN of_IN factors_NNS ._.
        One_CD immediately_RB apparent_JJ factor_NN that_WDT has_VBZ been_VBN examined_VBN is_VBZ
        age-related_JJ alterations_NNS in_IN renal_JJ Stx_NNP binding_JJ and_CC Stx_NNP
        receptor_NN (_( galactose-α-_JJ 1_CD ,_, 4_CD ,_, galactose-β-_JJ 1_CD ,_, 4_CD ,_,
        glucose-ceramide_JJ (_( Gb_NNP 3_LS )_) )_) expression_NN ._. An_DT autopsy_NN study_NN
        determined_VBN that_IN total_JJ kidney_NN Gb_NNP 3_CD levels_NNS were_VBD lower_JJR in_IN
        infants_NNS than_IN in_IN adults_NNS (_( although_IN only_RB two_CD individuals_NNS under_IN
        19_CD years_NNS of_IN age_NN were_VBD examined_VBN )_) [_NN 5_CD ]_NN ._. Another_DT study_NN using_VBG
        immunostaining_VBG of_IN biopsy_NN samples_NNS found_VBD that_DT glomeruli_NN from_IN
        infants_NNS (_( under_IN two_CD years_NNS of_IN age_NN )_) ,_, but_CC not_RB from_IN older_JJR
        children_NNS or_CC adults_NNS ,_, bound_VBN Stx_NNP [_NN 6_CD ]_NN ._. This_DT provocative_JJ
        finding_NN ,_, albeit_IN involving_VBG a_DT relatively_RB small_JJ sample_NN size_NN
        and_CC patients_NNS who_WP often_RB had_VBD glomerulopathies_NNS ,_, provided_VBD a_DT
        potential_JJ explanation_NN for_IN augmented_JJ glomerular_NN Stx_NNP
        sensitivity_NN in_IN young_JJ children_NNS ._. Confirmation_NNP of_IN these_DT
        observations_NNS is_VBZ needed_VBN ,_, however_RB they_PRP do_VBP suggest_VBP that_IN Gb_NNP 3_CD
        levels_NNS ,_, and_CC in_IN particular_JJ the_DT pattern_NN of_IN renal_JJ Gb_NNP 3_CD
        expression_NN ,_, may_MD be_VB a_DT factor_NN in_IN the_DT age-related_JJ incidence_NN of_IN
        renal_JJ injury_NN in_IN HUS_NNP ._.
        The_DT decreased_VBN incidence_NN of_IN HUS_NNP renal_JJ disease_NN in_IN
        adolescents_NNS and_CC adults_NNS raises_VBZ the_DT possibility_NN that_IN factors_NNS
        associated_VBN with_IN puberty_NN may_MD be_VB involved_VBN ._. There_EX have_VBP been_VBN no_DT
        studies_NNS ,_, to_TO our_PRP$ knowledge_NN ,_, that_WDT have_VBP examined_VBN the_DT effects_NNS
        of_IN puberty-related_JJ hormonal_NN alterations_NNS on_IN renal_JJ cell_NN
        sensitivity_NN to_TO Stx_NNP ._. Indeed_RB ,_, there_EX is_VBZ no_DT information_NN
        whatsoever_RB on_IN how_WRB any_DT sex_NN steroid_NN affects_VBZ Stx_NNP
        responsiveness_NNS of_IN any_DT cell_NN type_NN ._. It_PRP seemed_VBD reasonable_JJ ,_,
        therefore_RB ,_, to_TO examine_VB whether_IN sex_NN steroids_NNS (_( estrogen_NN ,_,
        progesterone_NN and_CC testosterone_NN )_) could_MD modify_VB the_DT cytotoxic_JJ
        effect_NN of_IN Stx_NNP on_IN renal_JJ cells_NNS ._. Further_RB ,_, since_IN Gb_NNP 3_CD levels_NNS may_MD
        be_VB altered_VBN with_IN aging_VBG ,_, the_DT effect_NN of_IN sex_NN steroids_NNS on_IN renal_JJ
        cell_NN Gb_NNP 3_CD expression_NN was_VBD examined_VBN ._.
        Several_JJ renal_JJ cell_NN types_NNS have_VBP been_VBN demonstrated_VBN to_TO
        respond_VB to_TO Stx_NNP ._. Based_VBN on_IN histologic_JJ evidence_NN ,_, glomerular_NN
        endothelial_NN cells_NNS have_VBP been_VBN invoked_VBN as_IN being_VBG primarily_RB
        involved_VBN in_IN HUS_NNP renal_JJ injury_NN [_NN 7_CD ]_NN ._. In_IN vitro_NN studies_NNS have_VBP
        demonstrated_VBN that_IN human_JJ glomerular_NN endothelial_NN cells_NNS (_( HGEN_NNP )_)
        bind_NN Stx-_NNP 1_CD and_CC are_VBP modestly_RB sensitive_JJ to_TO the_DT toxin_NN 's_POS
        cytotoxic_JJ effect_NN [_NN 8_CD ]_NN ._. Recent_JJ work_NN indicates_VBZ that_IN other_JJ
        renal_JJ cell_NN types_NNS may_MD be_VB Stx_NNP targets_NNS in_IN HUS_NNP :_: cultured_JJ human_JJ
        proximal_NN tubule_NN (_( HPT_NNP )_) [_NN 9_CD ]_NN and_CC human_JJ visceral_NN glomerular_NN
        epithelial_NN (_( HGEC_NNP )_) [_NN 10_CD ]_NN cells_NNS express_VBP abundant_JJ amounts_NNS of_IN
        Gb_NNP 3_CD and_CC are_VBP highly_RB sensitive_JJ to_TO the_DT cytotoxic_JJ effect_NN of_IN
        Stx-_NNP 1_CD ._. Consequently_RB ,_, the_DT current_JJ study_NN examined_VBD the_DT effect_NN
        of_IN sex_NN steroids_NNS on_IN Stx-_NNP 1_CD cytotoxicity_NN on_IN ,_, and_CC Gb_NNP 3_CD
        expression_NN by_IN ,_, HGEN_NNP ,_, HGEC_NNP and_CC HPT_NNP ._.
      
      
        Methods_NNP
        
          Cell_NNP culture_NN
          Primary_JJ cultures_NNS of_IN HPT_NNP were_VBD obtained_VBN from_IN Clonetics_NNP
          (_( San_NNP Diego_NNP ,_, CA_NNP )_) and_CC studied_VBN at_IN the_DT third_JJ passage_NN ._. The_DT
          identity_NN and_CC purity_NN of_IN these_DT cultures_NNS was_VBD established_VBN by_IN
          immunofluorescent_NN staining_VBG as_RB previously_RB described_VBD [_NN 9_CD ]_NN
          (_( in_IN addition_NN to_TO the_DT extensive_JJ characterization_NN by_IN
          Clonetics_NNP ,_, we_PRP have_VBP determined_VBN that_IN these_DT cells_NNS lack_VBP von_NNP
          Willebrand_NNP factor_NN and_CC platelet_NN endothelial_NN cell_NN adhesion_NN
          molecules_NNS (_( PECAM_NNP )_) ,_, but_CC are_VBP positive_JJ for_IN cytokeratin_NN ,_,
          immunofluorescence_NN and_CC alkaline_NN phosphatase_NN activity_NN )_) ._.
          HPT_NNP were_VBD maintained_VBN in_IN 1_CD :_: 1_CD Dulbecco_NNP 's_POS Modified_NNP Eagle_NNP
          Media_NNP :_: Ham_NNP 's_POS F_NN 12_CD containing_VBG 25_CD mM_NN HEPES_NNP ,_, 2_CD mM_NN L-_NNP glutamine_NN ,_,
          100_CD U_NNP /_NN ml_NN penicillin_NN /_NN streptomycin_NN ,_, 250_CD μg_NN /_NN L_NNP amphotericin_NN
          B_NNP ,_, 1_CD μg_NN /_NN ml_NN hydrocortisone_NN ,_, 10_CD μg_NN /_NN ml_NN insulin_NN ,_, 5_CD ._. 5_CD mg_NN /_NN ml_NN
          transferrin_NN ,_, 6_CD ._. 7_CD μg_NN /_NN ml_NN selenium_NN ,_, 0_CD ._. 2_CD gm_NN /_NN L_NNP ethanolamine_NN ,_,
          6_CD ._. 5_CD ng_NN /_NN ml_NN L-_NNP thyroxine_NN ,_, 10_CD ng_NN /_NN ml_NN epidermal_NN growth_NN factor_NN ,_,
          and_CC 10_CD %_NN fetal_JJ bovine_JJ serum_NN (_( FBS_NNP )_) ._. Hydrocortisone_NNP was_VBD
          present_JJ in_IN the_DT media_NNS since_IN HPT_NNP do_VBP not_RB grow_VB well_RB in_IN the_DT
          absence_NN of_IN corticosteroids_NNS (_( personal_JJ observation_NN )_) ._.
          Primary_JJ cultures_NNS of_IN HGEN_NNP were_VBD obtained_VBN from_IN Cell_NNP
          Systems_NNPS (_( Kirkland_NNP ,_, WA_NNP )_) and_CC studied_VBN at_IN the_DT third_JJ passage_NN ._.
          These_DT cells_NNS have_VBP been_VBN extensively_RB characterized_VBN by_IN Cell_NNP
          Systems_NNPS ;_: in_IN addition_NN ,_, we_PRP determined_VBD that_IN these_DT cells_NNS have_VBP
          von_NNP Willebrand_NNP factor_NN and_CC PECAM_NNP ,_, but_CC lack_NN cytokeratin_NN ,_,
          immunofluorescence_NN ._. HGEN_NNP were_VBD maintained_VBN in_IN EGM_NNP 2_CD -_: MV_NNP media_NNS
          (_( Clonetics_NNP )_) which_WDT contains_VBZ epidermal_NN growth_NN factor_NN ,_,
          hydrocortisone_NN ,_, vascular_NN endothelial_NN cell_NN growth_NN factor_NN ,_,
          basic_JJ fibroblast_NN growth_NN factor_NN ,_, insulin-like_JJ growth_NN
          factor-_NN 1_CD ,_, ascorbic_JJ acid_NN ,_, heparin_NN and_CC FBS_NNP ._.
          Primary_JJ cultures_NNS of_IN HGEC_NNP were_VBD obtained_VBN from_IN
          nephrectomies_NNS as_RB previously_RB described_VBD [_NN 10_CD ]_NN and_CC studied_VBN
          at_IN the_DT third_JJ passage_NN ._. Briefly_NNP ,_, glomeruli_NN were_VBD obtained_VBN by_IN
          sieving_VBG renal_JJ cortex_NN ,_, collagenase_NN digested_VBN ,_, and_CC cultured_JJ
          in_IN GEC_NNP media_NNS (_( Media_NNP 199_CD +_NN 20_CD %_NN FBS_NNP +_NN 100_CD μg_NN /_NN ml_NN Endothelial_NNP
          Growth_NNP Supplement_NNP (_( PerImmune_NNP ,_, Rockville_NNP ,_, MD_NNP )_) +_NN 100_CD U_NNP /_NN ml_NN
          penicillin_NN /_NN streptomycin_NN )_) ._. Primary_JJ cultures_NNS were_VBD passaged_JJ
          when_WRB 40_CD %_NN confluent_NN and_CC maintained_VBN in_IN GEC_NNP media_NNS
          thereafter_RB ._. Cell_NNP identity_NN and_CC purity_NN was_VBD determined_VBN as_RB
          previously_RB described_VBD [_NN 10_CD ]_NN :_: all_DT cells_NNS stained_JJ (_( by_IN
          immunofluorescence_NN )_) negative_JJ for_IN von_NNP Willebrand_NNP factor_NN ,_,
          PECAM_NNP and_CC anti-myosin_JJ ,_, but_CC were_VBD positive_JJ for_IN
          cytokeratin_NN ._.
        
        
          Stx-_NNP 1_CD cytotoxicity_NN and_CC Gb_NNP 3_CD expression_NN
          Confluent_NNP cells_NNS in_IN 96_CD well_RB plates_NNS were_VBD placed_VBN in_IN their_PRP$
          maintenance_NN media_NNS without_IN serum_NN for_IN 24_CD hr_NN and_CC exposed_VBN to_TO
          either_CC high_JJ or_CC low_JJ concentrations_NNS (_( see_VB Results_NNS )_) of_IN
          progesterone_NN ,_, β-estradiol_JJ or_CC testosterone_NN (_( all_DT from_IN Sigma_NNP
          Chemical_NNP Co_NNP ._. ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) for_IN 1_CD ,_, 2_CD or_CC 7_CD days_NNS in_IN
          serum-free_JJ media_NNS ._. Subsequently_RB ,_, Stx-_NNP 1_CD (_( purified_JJ in_IN our_PRP$
          laboratory_NN [_NN 9_CD ]_NN )_) was_VBD added_VBN for_IN 72_CD hr_NN at_IN concentrations_NNS
          of_IN 10_CD -_: 5_CD -_: 10_CD -_: 11_CD grams_NNS /_NN liter_NN ._. The_DT neutral_JJ red_JJ cytotoxicity_NN
          assay_NN was_VBD performed_VBN [_NN 9_CD ]_NN ._. Briefly_NNP ,_, 50_CD μg_NN /_NN ml_NN neutral_JJ red_NN
          in_IN Media_NNP 199_CD containing_VBG 5_CD %_NN serum_NN was_VBD added_VBN for_IN 2_CD -_: 3_CD hours_NNS
          at_IN 37_CD °_NN C_NNP ._. Cells_NNP were_VBD washed_VBN with_IN 1_CD %_NN CaCl_NNP 
          2_CD +_NN 1_CD %_NN formaldehyde_NN and_CC solubilized_JJ in_IN
          1_CD %_NN acetic_JJ acid_NN in_IN 50_CD %_NN ethanol_NN ._. Absorption_NNP was_VBD read_VBN at_IN 450_CD
          nm_NN ._.
          For_IN determination_NN of_IN Gb_NNP 3_CD content_NN ,_, cells_NNS grown_VBN in_IN
          6_CD -_: well_RB plates_NNS were_VBD placed_VBN in_IN serum-free_JJ media_NNS for_IN 24_CD hr_NN
          followed_VBN by_IN addition_NN of_IN the_DT steroids_NNS for_IN 1_CD ,_, 2_CD or_CC 7_CD days_NNS ._.
          Gb_NNP 3_CD was_VBD quantitated_JJ as_IN previously_RB described_VBD [_NN 9_CD ]_NN ._.
          Briefly_NNP ,_, cells_NNS were_VBD scraped_JJ off_RP the_DT plates_NNS ,_, centrifuged_JJ ,_,
          the_DT pellet_NN extracted_VBN in_IN chloroform_NN :_: methanol_NN :_: water_NN and_CC
          separated_JJ on_IN high_JJ performance_NN thin_JJ layer_NN
          chromatography-silica_JJ plates_NNS (_( Mallinckrodt_NNP Baker_NNP Inc_NNP ._. ,_,
          Paris_NNP ,_, KY_NNP )_) by_IN ascending_VBG chromatography_NN ._. The_DT plates_NNS were_VBD
          dried_VBN ,_, immersed_VBN in_IN 0_CD ._. 5_CD %_NN polyisobutylmethacrylate_NN in_IN
          acetone_NN ,_, and_CC sequentially_RB incubated_JJ with_IN Stx-_NNP 1_CD ,_,
          anti-_NN Stx-_NNP 1_CD monoclonal_NN antibody_NN (_( purified_JJ from_IN a_DT hybridoma_NN
          cell_NN line_NN ,_, 13_CD C_NNP 4_CD (_( ATCC_NNP ,_, Rockville_NNP ,_, MD_NNP )_) ,_, as_RB previously_RB
          described_VBD [_NN 9_CD ]_NN )_) ,_, and_CC 125_CD I-_NNP goat_NN anti-mouse_JJ IgG_NNP (_( DuPont_NNP
          NEN_NNP ,_, Boston_NNP ,_, MA_NNP )_) ._. Gb_NNP 3_CD concentrations_NNS were_VBD calculated_VBN by_IN
          densitometry_NN (_( Eagle_NNP Eye_NNP II_NNP ,_, Stratagene_NNP ,_, LaJolla_NNP ,_, CA_NNP )_) and_CC
          standardized_JJ to_TO total_VB protein_NN ._. Prior_RB to_TO centrifugation_NN ,_, a_DT
          cell_NN aliquot_NN was_VBD solubilized_JJ in_IN 0_CD ._. 1_CD N_NNP NaOH_NNP ,_, mixed_VBN with_IN
          Bradford_NNP reagent_NN (_( Bio-_NNP Rad_NNP ,_, Richmond_NNP ,_, CA_NNP )_) and_CC protein_NN
          concentration_NN determined_VBN by_IN measuring_VBG absorbance_NN at_IN 590_CD
          nm_NN ._.
        
        
          Statistics_NNS
          All_DT data_NNS were_VBD analyzed_VBN by_IN one_CD way_NN analysis_NN of_IN
          variance_NN ._. Individual_JJ conditions_NNS were_VBD compared_VBN using_VBG
          Student_NNP 's_POS t-test_JJ after_IN the_DT Bonferroni_NNP correction_NN ._. 
          P_NN values_NNS <_NN 0_CD ._. 05_CD were_VBD taken_VBN as_IN
          significant_JJ ._.
        
      
      
        Results_NNS
        Stx-_NNP 1_CD (_( 72_CD hr_NN exposure_NN to_TO toxin_NN )_) dose-dependently_JJ killed_VBN
        HGEN_NNP ,_, HGEC_NNP and_CC HPT_NNP (_( Figure_NN 1_LS )_) ._. In_IN HGEN_NNP ,_, Stx-_NNP 1_CD had_VBD an_DT LD_NNP 50_CD
        of_IN about_IN 10_CD -_: 5_CD g_SYM /_NN L_NNP (_( 140_CD pM_NN )_) ,_, while_IN in_IN HGEC_NNP the_DT LD_NNP 
        50_CD for_IN Stx-_NNP was_VBD about_IN 10_CD -_: 8_CD g_SYM /_NN L_NNP (_( 140_CD fM_NN )_)
        and_CC in_IN HPT_NNP the_DT LD_NNP 
        50_CD for_IN Stx_NNP was_VBD about_IN 10_CD -_: 9_CD ._. 5_LS g_SYM /_NN L_NNP (_( 4_CD ._. 4_LS
        fM_NN )_) ._.
        Exposure_NNP for_IN 1_CD ,_, 2_CD or_CC 7_CD days_NNS to_TO high_JJ (_( 1_CD μM_NN )_) or_CC
        physiologic_JJ concentrations_NNS (_( reference_NN range_NN of_IN physiologic_JJ
        steroid_NN concentrations_NNS based_VBN on_IN Barnes_NNP Hospital_NNP Laboratory_NNP
        Manual_NNP [_NN 11_CD ]_NN )_) of_IN progesterone_NN (_( 30_CD nM_NN )_) ,_, β-estradiol_JJ (_( 100_CD
        pM_NN )_) ,_, or_CC testosterone_NN (_( 30_CD nM_NN )_) had_VBD no_DT effect_NN on_IN HGEN_NNP (_( Table_NNP
        1_LS )_) ,_, HGEC_NNP (_( Table_NNP 2_LS )_) or_CC HPT_NNP (_( Table_NNP 3_LS )_) responsiveness_NNS to_TO
        Stx-_NNP 1_CD ._. For_IN the_DT sake_NN of_IN brevity_NN ,_, the_DT tables_NNS illustrate_VBP the_DT
        effect_NN of_IN 10_CD -_: 5_CD ,_, 10_CD -_: 8_CD ,_, and_CC 10_CD -_: 11_CD g_SYM /_NN L_NNP Stx-_NNP 1_CD ,_, however_RB a_DT full_JJ
        dose-response_JJ from_IN 10_CD -_: 5_CD -_: 10_CD -_: 11_CD g_SYM /_NN L_NNP Stx-_NNP 1_CD ,_, in_IN ten-fold_JJ
        concentration_NN increments_NNS ,_, was_VBD done_VBN for_IN each_DT condition_NN :_:
        there_EX was_VBD also_RB no_DT significant_JJ effect_NN of_IN these_DT other_JJ
        concentrations_NNS of_IN sex_NN steroids_NNS on_IN the_DT cytotoxic_JJ effects_NNS of_IN
        Stx-_NNP 1_CD on_IN any_DT of_IN the_DT renal_JJ cell_NN types_NNS ._. In_IN addition_NN ,_,
        physiologic_JJ or_CC pharmacologic_JJ concentrations_NNS of_IN
        progesterone_NN ,_, estradiol_NN or_CC testosterone_NN had_VBD no_DT effect_NN on_IN
        baseline_NN (_( without_IN exposure_NN to_TO Stx-_NNP 1_LS )_) HGEN_NNP ,_, HGEC_NNP or_CC HPT_NNP
        survival_NN ._.
        The_DT effect_NN of_IN 1_CD ,_, 2_CD or_CC 7_CD days_NNS of_IN exposure_NN to_TO physiologic_JJ
        or_CC pharmacologic_JJ concentrations_NNS of_IN progesterone_NN ,_, estradiol_NN
        or_CC testosterone_NN on_IN Gb_NNP 3_CD expression_NN by_IN HGEN_NNP ,_, HGEC_NNP or_CC HPT_NNP was_VBD
        also_RB examined_VBN ._. A_DT representative_NN blot_NN of_IN Gb_NNP 3_CD content_NN is_VBZ
        shown_VBN in_IN Figure_NN 2_CD (_( figure_NN illustrates_VBZ 2_CD day_NN steroid_NN exposure_NN
        in_IN HPT_NNP )_) to_TO demonstrate_VB that_IN Gb_NNP 3_CD isolated_VBN from_IN cells_NNS
        migrated_JJ on_IN the_DT gel_NN at_IN the_DT same_JJ position_NN as_IN purified_JJ Gb_NNP 3_CD ._.
        As_IN for_IN Stx-cytotoxicity_NNP ,_, none_NN of_IN the_DT steroids_NNS ,_, at_IN any_DT dose_NN
        or_CC exposure_NN time_NN ,_, modified_VBN Gb_NNP 3_CD content_NN in_IN any_DT cell_NN type_NN (_( n_NN
        =_SYM 3_CD each_DT condition_NN ,_, data_NNS not_RB shown_VBN )_) ._.
        Immunoreactive_NNP steroid_NN concentration_NN was_VBD determined_VBN in_IN
        media_NNS samples_NNS at_IN the_DT start_NN and_CC conclusion_NN of_IN the_DT 7_CD day_NN
        experiment_NN (_( analyzed_VBD in_IN clinical_JJ laboratory_NN at_IN Associated_NNP
        Regional_NNP University_NNP Pathologists_NNP ,_, Salt_NNP Lake_NNP City_NNP ,_, UT_NNP )_) in_IN
        order_NN to_TO determine_VB the_DT stability_NN of_IN the_DT added_VBN steroids_NNS ._.
        Estradiol_NNP and_CC testosterone_NN concentrations_NNS did_VBD not_RB vary_VB over_IN
        1_CD ,_, 2_CD or_CC 7_CD days_NNS in_IN culture_NN media_NNS ._. Progesterone_NNP levels_NNS also_RB
        did_VBD not_RB fall_VB after_IN 1_CD -_: 2_CD days_NNS in_IN culture_NN media_NNS ,_, however_RB after_IN
        7_CD days_NNS in_IN media_NNS the_DT progesterone_NN concentration_NN
        significantly_RB dropped_VBD (_( 80_CD %_NN decrease_NN )_) ._. Consequently_RB ,_, fresh_JJ
        progesterone_NN was_VBD added_VBN to_TO the_DT 7_CD day_NN experiments_NNS every_DT two_CD
        days_NNS ._.
        The_DT failure_NN of_IN steroids_NNS to_TO affect_VB Stx_NNP cytotoxicity_NN was_VBD
        not_RB due_JJ to_TO inactivity_NN of_IN the_DT steroid_NN preparations_NNS ._. Similar_JJ
        preparations_NNS and_CC concentrations_NNS of_IN steroids_NNS from_IN the_DT same_JJ
        supplier_NN (_( Sigma_NNP )_) were_VBD tested_VBN by_IN Dr_NNP ._. Wayne_NNP Meikle_NNP in_IN the_DT
        Division_NNP of_IN Endocrinology_NNP at_IN the_DT University_NNP of_IN Utah_NNP using_VBG
        an_DT in-house_JJ estrogen_NN and_CC progesterone_NN binding_JJ assay_NN and_CC a_DT
        testosterone-dependent_JJ stimulation_NN of_IN prostate_NN cancer_NN cell_NN
        apoptosis_NNS assay_NN [_NN 12_CD ]_NN ;_: all_PDT the_DT steroids_NNS retained_VBD biologic_JJ
        activity_NN (_( data_NNS not_RB shown_VBN )_) ._.
      
      
        Discussion_NNP and_CC Conclusion_NNP
        The_DT reasons_NNS why_WRB HUS_NNP primarily_RB affects_VBZ children_NNS are_VBP
        unknown_JJ ._. It_PRP is_VBZ evident_JJ that_IN the_DT peak_NN incidence_NN of_IN HUS_NNP
        occurs_VBZ in_IN very_RB young_JJ children_NNS (_( 1_CD -_: 2_CD years_NNS of_IN age_NN )_) ._. The_DT
        factors_NNS responsible_JJ for_IN this_DT apparent_JJ heightened_VBN
        sensitivity_NN to_TO infection_NN with_IN Stx-expressing_NNP bacteria_NNS have_VBP
        not_RB been_VBN extensively_RB investigated_VBN and_CC were_VBD not_RB examined_VBN in_IN
        the_DT current_JJ study_NN ._. Indeed_RB ,_, it_PRP is_VBZ conceivable_JJ that_IN not_RB all_DT
        of_IN the_DT factors_NNS involved_VBN in_IN HUS_NNP occurrence_NN in_IN young_JJ children_NNS
        are_VBP identical_JJ to_TO those_DT involved_VBN in_IN the_DT diminished_VBN HUS_NNP
        incidence_NN in_IN adolescents_NNS and_CC adults_NNS ._. Numerous_JJ factors_NNS could_MD
        be_VB involved_VBN in_IN age-related_JJ Stx_NNP sensitivity_NN ,_, including_VBG
        differences_NNS in_IN the_DT degree_NN of_IN enteric_JJ invasion_NN by_IN
        Stx-producing_NNP 
        E_NNP ._. coli_NNS ;_: in_IN Stx_NNP transport_NN across_IN the_DT
        gut_NN ,_, in_IN circulating_VBG red_JJ or_CC white_JJ blood_NN cell_NN toxin_NN binding_JJ
        and_CC delivery_NN to_TO the_DT kidney_NN ,_, in_IN the_DT immune_JJ response_NN to_TO Stx_NNP ,_,
        in_IN renal_JJ Stx_NNP binding_JJ ,_, and_CC /_NN or_CC in_IN intrinsic_JJ or_CC
        cofactor-regulated_JJ (_( e_SYM ._. g_SYM ._. inflammatory_JJ cytokines_NNS )_) renal_JJ Stx_NNP
        responsiveness_NNS ._. The_DT current_JJ study_NN evaluated_VBD one_CD of_IN these_DT
        possibilities_NNS ,_, namely_RB that_IN renal_JJ cell_NN Stx-_NNP 1_CD responsiveness_NNS
        decreases_NNS with_IN age_NN due_JJ ,_, at_IN least_JJS partially_RB ,_, to_TO hormonal_NN
        changes_NNS associated_VBN with_IN puberty_NN ._. As_IN stated_VBN earlier_RBR ,_, there_EX
        is_VBZ no_DT precedent_NN in_IN the_DT literature_NN for_IN examination_NN of_IN the_DT
        effect_NN of_IN sex_NN steroids_NNS on_IN Stx_NNP responsiveness_NNS ,_, however_RB ,_, the_DT
        coincidental_JJ fall_NN in_IN clinically_RB apparent_JJ HUS_NNP in_IN adolescents_NNS
        and_CC adults_NNS [_NN 1_CD ]_NN raises_VBZ the_DT possibility_NN that_IN hormonal_NN
        changes_NNS associated_VBN with_IN puberty_NN induce_VB a_DT relatively_RB
        Stx-resistant_NNP state_NN in_IN the_DT kidney_NN ._.
        HGEN_NNP ,_, HGEC_NNP and_CC HPT_NNP were_VBD chosen_VBN for_IN examination_NN in_IN this_DT
        study_NN because_IN these_DT cell_NN types_NNS ,_, at_IN least_JJS 
        in_IN vitro_NN ,_, have_VBP been_VBN shown_VBN to_TO be_VB
        injured_VBN by_IN Stx-_NNP 1_CD [_NN 6_CD 7_CD 8_CD ]_NN ._. Mesangial_NNP cells_NNS were_VBD not_RB
        examined_VBN since_IN Stx-_NNP 1_CD has_VBZ not_RB been_VBN demonstrated_VBN to_TO affect_VB
        their_PRP$ viability_NN [_NN 13_CD ]_NN ._. Previous_JJ studies_NNS have_VBP separately_RB
        examined_VBN the_DT cytotoxic_JJ effect_NN of_IN Stx-_NNP 1_CD on_IN HGEN_NNP [_NN 8_CD ]_NN ,_, HGEC_NNP
        [_NN 10_CD ]_NN ,_, and_CC HPT_NNP [_NN 9_CD ]_NN ,_, however_RB this_DT is_VBZ the_DT first_JJ study_NN to_TO
        directly_RB compare_VB Stx-_NNP 1_CD sensitivity_NN of_IN these_DT renal_JJ cell_NN
        types_NNS ._. These_DT data_NNS indicate_VBP that_IN ,_, as_IN suggested_VBN from_IN the_DT
        previous_JJ studies_NNS ,_, within_IN the_DT limits_NNS of_IN the_DT cell_NN culture_NN
        system_NN ,_, HPT_NNP are_VBP the_DT most_RBS sensitive_JJ to_TO Stx-_NNP 1_CD cytotoxicity_NN of_IN
        the_DT three_CD cell_NN types_NNS ,_, HGEC_NNP are_VBP slightly_RB less_RBR sensitive_JJ ,_, and_CC
        HGEN_NNP are_VBP at_IN least_JJS three_CD orders_NNS of_IN magnitude_NN less_RBR sensitive_JJ
        than_IN either_DT HGEC_NNP or_CC HPT_NNP ._. Such_JJ differential_NN sensitivity_NN is_VBZ
        quite_RB interesting_JJ ,_, particularly_RB considering_VBG that_DT glomerular_NN
        endothelial_NN cell_NN damage_NN is_VBZ a_DT prominent_JJ histologic_JJ feature_NN
        in_IN biopsies_NNS obtained_VBN from_IN patients_NNS with_IN clinically_RB well_RB
        established_VBN HUS_NNP [_NN 7_CD ]_NN ._. The_DT significance_NN of_IN these_DT
        observations_NNS remains_VBZ ,_, therefore_RB ,_, to_TO be_VB determined_VBN ._. Although_IN
        speculative_JJ ,_, it_PRP is_VBZ tempting_JJ to_TO propose_VB that_IN HPT_NNP and_CC HGEC_NNP
        may_MD be_VB early_JJ targets_NNS of_IN Stx-_NNP 1_CD and_CC that_IN this_DT could_MD play_VB a_DT
        role_NN in_IN the_DT pathophysiologic_JJ processes_NNS that_WDT characterize_VBP
        renal_JJ injury_NN in_IN HUS_NNP ._.
        Estrogen_NNP ,_, progesterone_NN or_CC testosterone_NN did_VBD not_RB affect_VB
        Stx-_NNP 1_CD mediated_JJ renal_JJ cell_NN cytotoxicity_NN or_CC Gb_NNP 3_CD expression_NN ._.
        Cells_NNP were_VBD exposed_VBN to_TO the_DT steroids_NNS for_IN up_IN to_TO one_CD week_NN in_IN
        order_NN to_TO allow_VB time_NN for_IN steroid-regulated_JJ gene_NN
        transcription_NN and_CC protein_NN expression_NN ._. In_IN addition_NN ,_, both_DT
        physiologic_JJ and_CC pharmacologic_JJ concentrations_NNS of_IN steroids_NNS
        were_VBD utilized_JJ ._. Despite_IN these_DT efforts_NNS to_TO be_VB insure_VB that_IN the_DT
        system_NN was_VBD optimized_JJ in_IN order_NN to_TO detect_VB a_DT steroid-mediated_JJ
        alteration_NN of_IN Stx_NNP responsiveness_NNS ,_, the_DT concern_NN still_RB exists_VBZ
        that_IN this_DT system_NN may_MD not_RB really_RB reflect_VB the_DT influences_NNS of_IN
        sex_NN steroids_NNS in_IN vivo_NN ._. Indeed_RB ,_, one_PRP might_MD argue_VB that_IN an_DT
        animal_NN model_NN ,_, in_IN which_WDT the_DT testes_NNS or_CC ovaries_NNS are_VBP removed_VBN
        and_CC the_DT animals_NNS are_VBP given_VBN Stx_NNP in_IN the_DT presence_NN and_CC absence_NN
        of_IN steroid_NN replacement_NN ,_, would_MD be_VB better_JJR ._. Such_JJ studies_NNS
        would_MD ,_, however_RB ,_, be_VB problematic_JJ ._. Traditional_JJ animal_NN models_NNS ,_,
        such_JJ as_IN mice_NNS ,_, rats_NNS ,_, rabbits_NNS or_CC pigs_NNS do_VBP not_RB develop_VB typical_JJ
        renal_JJ disease_NN when_WRB given_VBN either_CC Stx_NNP or_CC 
        E_NNP ._. coli_NNS 0157_CD :_: H_NNP 7_CD [_NN 14_CD ]_NN ._. Further_RB ,_,
        animal_NN models_NNS that_IN most_RBS closely_RB reflect_VB human_JJ HUS_NNP are_VBP only_RB
        in_IN the_DT early_JJ stages_NNS of_IN development_NN [_NN 14_CD ]_NN ._. Hence_RB ,_, the_DT cell_NN
        culture_NN system_NN remains_VBZ the_DT most_RBS reasonable_JJ means_VBZ to_TO assess_VB
        an_DT effect_NN of_IN sex_NN steroids_NNS on_IN renal_JJ cell_NN Stx-_NNP 1_CD
        responsiveness_NNS ;_: such_JJ systems_NNS have_VBP clearly_RB been_VBN demonstrated_VBN
        to_TO be_VB responsive_JJ to_TO sex_NN steroids_NNS (_( e_SYM ._. g_SYM ._.
        testosterone-regulated_JJ KAP_NNP promoter_NN activity_NN in_IN proximal_NN
        tubule_NN cells_NNS [_NN 15_CD ]_NN as_RB well_RB as_IN estrogen-regulated_JJ
        endothelial_NN cell_NN function_NN [_NN 16_CD ]_NN )_) ._. Given_VBN these_DT
        limitations_NNS ,_, our_PRP$ data_NNS suggest_VBP that_IN sex_NN steroids_NNS do_VBP not_RB
        alter_VB renal_JJ cell_NN sensitivity_NN to_TO the_DT cytotoxic_JJ effects_NNS of_IN
        this_DT Stx-_NNP 1_CD ._. Consequently_RB ,_, the_DT reasons_NNS why_WRB clinically_RB
        apparent_JJ HUS_NNP primarily_RB occurs_VBZ in_IN children_NNS remains_VBZ to_TO be_VB
        determined_VBN ._.
      
      
        List_NN of_IN Abbreviations_NNP
        HUS_NNP hemolytic-uremic_JJ syndrome_NN
        HGEN_NNP human_JJ glomerular_NN endothelial_NN cells_NNS
        HGEC_NNP human_JJ glomerular_NN visceral_NN epithelial_NN cells_NNS
        HPT_NNP human_JJ proximal_NN tubule_NN cells_NNS
        Stx-_NNP 1_CD Shiga_NNP toxin-_NN 1_CD
        Gb_NNP 3_CD galactose-α-_JJ 1_CD ,_, 4_CD ,_, galactose-β-_JJ 1_CD ,_, 4_CD ,_,
        glucose-ceramide_JJ
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' Contributions_NNP
        Author_NN 1_CD performed_VBD the_DT analysis_NN of_IN cytotoxicity_NN ,_,
        maintained_VBN cell_NN culture_NN and_CC was_VBD involved_VBN in_IN experimental_JJ
        design_NN ._. Author_NN 2_CD performed_VBN Gb_NNP 3_CD analysis_NN and_CC assisted_VBN with_IN
        cell_NN culture_NN ._. Author_NN 3_CD designed_VBN ,_, interpreted_VBN and_CC supervised_VBD
        the_DT experiments_NNS ._.
      
    
  
